openPR Logo
Press release

Candidiasis Therapeutics Market Value Chain and Forecast 2016-2026

07-27-2016 11:04 AM CET | Health & Medicine

Press release from: Future Market Insights

Candidiasis Therapeutics Market Value Chain and Forecast

Candidiasis or commonly known as thrush is a fungal infection affecting men and women of all age groups. When thrush extends into the throat it causes esophagitis. It is also known by other names such as candidosis, moniliasis, and oidiomycosis. The effects of this infection are seen on a dermal, internal and systemic level wherein it is known as candidemia or intestinal thrush. The market is dynamic due to widespread occurrence of this disease, in particular as recurrent infections, limitations of safe and efficacious antifungals as well as the lack of reliable preventative approaches. The major drug classes for treatment include azoles, polyenes and echinocandins.

Candidiasis Therapeutics Market: Drivers and Restraints

Increase in number of patients affected by candidiasis infection, increasing consumer inclination towards maintaining aesthetic appearance and growing awareness for candidiasis infection in developing markets are expected to boost the market growth over the forecast period. This is mainly due to urbanization and rising hygiene awareness in developing countries. Less R&D activity in this sector and availability of alternative treatments is expected to restraint the candidiasis therapeutics market over the forecast year. The factors such as narrow pipeline molecules and competition from herbal medicines and alternate therapies such as probiotic are expected to restrain the market growth over the forecast period.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1327

Candidiasis Therapeutics Market: Segmentation

Candidiasismarket is classified on the basis of route of administration, drug type, anatomy type and distribution channel:

Based on route of administration, the global candidiasis therapeutics marketcan be segmented as follows:

Injection

Ointment

Oral

Based on class of drugs, the global candidiasis therapeutics marketcan be segmented as follows:

Polyene

Azole

Echinocandin

Miscellaneou

Based on anatomy type, the global candidiasis therapeutics marketcan be segmented as follows:

Oral Candidiasis

Vulvovaginal Candidiasis

Cutaneous Candidiasis

Invasive Candidiasis

Systemic Candidiasis

Based on distribution channel, the global candidiasis therapeutics market can be segmented as follows:

Hospitals

Clinics

Retail Pharmacies

Drug Stores

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1327

Candidiasis Therapeutics Market: Overview

The global market for anti-candidiasis agents is expected to grow with a healthy CAGR over the forecast period. The market for systemic candidiasis is driven by increases in the susceptible immune compromised patient pool. Thrush occurs in approximately 2–5 percent of healthy new born and affect them mainly during their first year of life. Over 1 million adult women and adolescent girls in the U. S. develop vaginal yeast infections each year.

Candidiasis Therapeutics Market: Region-wise Outlook

Based on geographic regions, gastroesophageal reflux disease therapeutics market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Japan, Asia Pacific and Middle East & Africa. The disease is growing globally and is not restricted to any particular region. North America and Europe region account for the largest markets revenue share due to higher awareness of the disease amongst individuals and also availability of better treatment. Asia-Pacific also offers considerable opportunities owing to low unmet need in this region.

Browse Full Report@ http://www.futuremarketinsights.com/reports/candidiasis-therapeutics-market

Candidiasis Therapeutics Market: Key Players

The anti-fungal candidiasis treatment is a highly fragmented mature market with a large number of generics. Major players in the market are Bayer, Teva Pharmaceuticals, Stellar Pharma, Pfizer, Wockhardt, Ranbaxy, Bristol Laboratories, Glenmark Pharmaceuticals, Taro Pharmaceuticals and Perrigo among many other local players. There are several types of formulations available for treatment based on the modality such as pills, powders, ointments and injectable. In 2013, Astellas Pharma reported positive results from its phase III drug isavuconazole which is one of the only first-in-class molecules expected to enter the market.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Candidiasis Therapeutics Market Value Chain and Forecast 2016-2026 here

News-ID: 352126 • Views:

More Releases from Future Market Insights

AI in IoT Market Set to Reach USD 172.8 Billion by 2035 with 6.4% CAGR Amid Rising Digital Transformation
AI in IoT Market Set to Reach USD 172.8 Billion by 2035 with 6.4% CAGR Amid Risi …
The AI in IoT market is witnessing rapid expansion as enterprises across industries increasingly integrate artificial intelligence with Internet of Things (IoT) systems. Valued at USD 92.9 billion in 2025, the market is projected to reach USD 172.8 billion by 2035, representing a compound annual growth rate of 6.4%. The integration of AI into IoT infrastructure enables predictive analytics, real-time monitoring, and automated control across multiple applications, transforming how businesses
Catalog Management System Market Poised to Reach USD 4.2 Billion by 2035 with Advanced Technology Integration
Catalog Management System Market Poised to Reach USD 4.2 Billion by 2035 with Ad …
The catalog management system (CMS) market is experiencing steady and strategic growth, with its value projected to rise from USD 1.9 billion in 2025 to USD 4.2 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8.1%. The market expansion is primarily fueled by businesses' growing need for centralized product information, streamlined digital operations, and enhanced customer experiences across increasingly complex sales channels. As e-commerce continues to penetrate global
HIFI Electronics Market Set to Double by 2035, Driven by Premium Audio and Technological Innovation
HIFI Electronics Market Set to Double by 2035, Driven by Premium Audio and Techn …
The global HIFI electronics market is poised for remarkable growth over the next decade, projected to expand from USD 17,243.4 million in 2025 to USD 37,227.2 million by 2035. This impressive growth trajectory, representing an absolute increase of nearly USD 19,983.8 million and a compound annual growth rate (CAGR) of 8%, reflects the rising global appetite for premium audio experiences and high-fidelity sound reproduction across personal and professional applications. The expansion
Interrogation Table Market to Reach USD 435.7 Million by 2035, Driven by Security Infrastructure Expansion
Interrogation Table Market to Reach USD 435.7 Million by 2035, Driven by Securit …
The global interrogation table market, valued at USD 321.1 million in 2025, is set to grow steadily to USD 435.7 million by 2035, registering a moderate CAGR of 3.1%. This trajectory reflects a market gradually approaching maturity, where incremental demand for specialized security furniture outweighs rapid expansion. The early stage from 2025 to 2028 is expected to see modest increases in annual revenues, primarily linked to new infrastructure development across

All 5 Releases


More Releases for Candidiasis

Candidiasis Market New Product Development & Latest Trends
Introduction Candidiasis, a fungal infection caused by Candida species, represents a major healthcare challenge worldwide. While Candida albicans is the most common pathogen, emerging strains such as Candida auris are raising global concerns due to their high resistance to antifungal drugs. Candidiasis can affect the mouth (oral thrush), genital areas, bloodstream, and internal organs, with systemic infections often proving life-threatening, especially in immunocompromised patients. The growing prevalence of hospital-acquired infections (HAIs), rising
Rising Fungal Infection Rates Fueling Growth In The Candidiasis Therapeutics Mar …
The Candidiasis Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Candidiasis Therapeutics Market Size and Projected Growth Rate? Recent years have seen consistent growth in the size of the market for candidiasis therapeutics. This is predicted to further expand from $3.19 billion
Acute Vulvovaginal Candidiasis Market Beyond Douching: New Treatment Options Dri …
Acute Vulvovaginal Candidiasis Market worth $ 485.54 Million by 2030 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Acute Vulvovaginal Candidiasis Market- by Drug Type (Clotrimazole, Nystatin, Fluconazole, , Terbinafine, Terconazole and Other Drug Types), Route of Administration (Oral, Intravenous and Topical), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), Trends, Industry Competition Analysis, Revenue and Forecast
Recurrent Vulvovaginal Candidiasis Market - Defeating Recurrent Vulvovaginal Can …
Newark, New Castle, USA: The "Recurrent Vulvovaginal Candidiasis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Recurrent Vulvovaginal Candidiasis Market: https://www.growthplusreports.com/report/recurrent-vulvovaginal-candidiasis-market/8832 This latest report researches the industry structure,
Candidiasis Epidemiology Insights to 2025
Publisher " Candidiasis - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Candidiasis in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Candidiasis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with
Candidiasis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Candidiasis - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Candidiasis - Pipeline Review, H1 2017, provides an overview of the Candidiasis (Infectious Disease) pipeline landscape. Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. A Candida infection of the skin